Plasminogen activator/plasminogen activator inhibitor-1 and cytokine modulation by the PROACT™ System

Marie Louise Ivarsson, Michael Peter Diamond, Peter Falk, Lena Holmdahl

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objective: To examine the effects of the PROACT treatment on the fibrinolytic system and inflammatory cytokines in human peritoneum. Design: Controlled clinical study. Setting: University hospital. Patient(s): Nine subjects undergoing laparotomy had peritoneal samples taken at the incision. Intervention(s): The PROACT applicator was inserted through the peritoneal incision, and treatment of peritoneum was performed twice. A peritoneal sample was taken from one treated area. At closure, the second treated sample and an additional control sample were taken. All four samples were snap frozen in liquid nitrogen. Samples were homogenized and protein content extracted. Main Outcome Measure(s): Concentrations of total and active transforming growth factor-beta 1 (TGF-β1), tumor necrosis factor-alpha (TNF-α), tissue-type plasminogen activator (t-PA), urokinase plasminogen activator (uPA), and plasminogen activator inhibitor 1 (PAI-1) were obtained. Result(s): Total TGF-β1 at opening was 30% less in treated samples. At closure, active TGF-β1 increased significantly (163%) in control samples and not in treated samples. Tumor necrosis factor alpha was detectable only in control samples at closure. During surgery, tPA levels showed a marked decrease in control samples vs. a small increase in treated samples. Levels of uPA increased significantly only in the control samples. In control samples, tPA/PAI-1 ratio was two thirds of treated sample ratio. Conclusion(s): Heating of the peritoneum with the PROACT™ System modulates the biologic tissue response to induce effects that would be consistent with inhibition of postoperative adhesion development.

Original languageEnglish (US)
Pages (from-to)987-992
Number of pages6
JournalFertility and Sterility
Volume79
Issue number4
DOIs
StatePublished - Apr 1 2003
Externally publishedYes

Fingerprint

Plasminogen Activators
Peritoneum
Plasminogen Activator Inhibitor 1
Transforming Growth Factor beta
Urokinase-Type Plasminogen Activator
Cytokines
Tumor Necrosis Factor-alpha
Tissue Plasminogen Activator
Heating
Laparotomy
Nitrogen
Outcome Assessment (Health Care)
Therapeutics
Proteins

Keywords

  • Adhesions
  • Incision line
  • Plasminogen activator
  • Plasminogen activator inhibitor-1
  • Postoperative adhesions
  • PROACT™ System
  • Transforming growth factor-beta

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Plasminogen activator/plasminogen activator inhibitor-1 and cytokine modulation by the PROACT™ System. / Ivarsson, Marie Louise; Diamond, Michael Peter; Falk, Peter; Holmdahl, Lena.

In: Fertility and Sterility, Vol. 79, No. 4, 01.04.2003, p. 987-992.

Research output: Contribution to journalArticle

@article{41381919c9134cfe86be927ef9f27861,
title = "Plasminogen activator/plasminogen activator inhibitor-1 and cytokine modulation by the PROACT™ System",
abstract = "Objective: To examine the effects of the PROACT treatment on the fibrinolytic system and inflammatory cytokines in human peritoneum. Design: Controlled clinical study. Setting: University hospital. Patient(s): Nine subjects undergoing laparotomy had peritoneal samples taken at the incision. Intervention(s): The PROACT applicator was inserted through the peritoneal incision, and treatment of peritoneum was performed twice. A peritoneal sample was taken from one treated area. At closure, the second treated sample and an additional control sample were taken. All four samples were snap frozen in liquid nitrogen. Samples were homogenized and protein content extracted. Main Outcome Measure(s): Concentrations of total and active transforming growth factor-beta 1 (TGF-β1), tumor necrosis factor-alpha (TNF-α), tissue-type plasminogen activator (t-PA), urokinase plasminogen activator (uPA), and plasminogen activator inhibitor 1 (PAI-1) were obtained. Result(s): Total TGF-β1 at opening was 30{\%} less in treated samples. At closure, active TGF-β1 increased significantly (163{\%}) in control samples and not in treated samples. Tumor necrosis factor alpha was detectable only in control samples at closure. During surgery, tPA levels showed a marked decrease in control samples vs. a small increase in treated samples. Levels of uPA increased significantly only in the control samples. In control samples, tPA/PAI-1 ratio was two thirds of treated sample ratio. Conclusion(s): Heating of the peritoneum with the PROACT™ System modulates the biologic tissue response to induce effects that would be consistent with inhibition of postoperative adhesion development.",
keywords = "Adhesions, Incision line, Plasminogen activator, Plasminogen activator inhibitor-1, Postoperative adhesions, PROACT™ System, Transforming growth factor-beta",
author = "Ivarsson, {Marie Louise} and Diamond, {Michael Peter} and Peter Falk and Lena Holmdahl",
year = "2003",
month = "4",
day = "1",
doi = "10.1016/S0015-0282(02)04851-3",
language = "English (US)",
volume = "79",
pages = "987--992",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Plasminogen activator/plasminogen activator inhibitor-1 and cytokine modulation by the PROACT™ System

AU - Ivarsson, Marie Louise

AU - Diamond, Michael Peter

AU - Falk, Peter

AU - Holmdahl, Lena

PY - 2003/4/1

Y1 - 2003/4/1

N2 - Objective: To examine the effects of the PROACT treatment on the fibrinolytic system and inflammatory cytokines in human peritoneum. Design: Controlled clinical study. Setting: University hospital. Patient(s): Nine subjects undergoing laparotomy had peritoneal samples taken at the incision. Intervention(s): The PROACT applicator was inserted through the peritoneal incision, and treatment of peritoneum was performed twice. A peritoneal sample was taken from one treated area. At closure, the second treated sample and an additional control sample were taken. All four samples were snap frozen in liquid nitrogen. Samples were homogenized and protein content extracted. Main Outcome Measure(s): Concentrations of total and active transforming growth factor-beta 1 (TGF-β1), tumor necrosis factor-alpha (TNF-α), tissue-type plasminogen activator (t-PA), urokinase plasminogen activator (uPA), and plasminogen activator inhibitor 1 (PAI-1) were obtained. Result(s): Total TGF-β1 at opening was 30% less in treated samples. At closure, active TGF-β1 increased significantly (163%) in control samples and not in treated samples. Tumor necrosis factor alpha was detectable only in control samples at closure. During surgery, tPA levels showed a marked decrease in control samples vs. a small increase in treated samples. Levels of uPA increased significantly only in the control samples. In control samples, tPA/PAI-1 ratio was two thirds of treated sample ratio. Conclusion(s): Heating of the peritoneum with the PROACT™ System modulates the biologic tissue response to induce effects that would be consistent with inhibition of postoperative adhesion development.

AB - Objective: To examine the effects of the PROACT treatment on the fibrinolytic system and inflammatory cytokines in human peritoneum. Design: Controlled clinical study. Setting: University hospital. Patient(s): Nine subjects undergoing laparotomy had peritoneal samples taken at the incision. Intervention(s): The PROACT applicator was inserted through the peritoneal incision, and treatment of peritoneum was performed twice. A peritoneal sample was taken from one treated area. At closure, the second treated sample and an additional control sample were taken. All four samples were snap frozen in liquid nitrogen. Samples were homogenized and protein content extracted. Main Outcome Measure(s): Concentrations of total and active transforming growth factor-beta 1 (TGF-β1), tumor necrosis factor-alpha (TNF-α), tissue-type plasminogen activator (t-PA), urokinase plasminogen activator (uPA), and plasminogen activator inhibitor 1 (PAI-1) were obtained. Result(s): Total TGF-β1 at opening was 30% less in treated samples. At closure, active TGF-β1 increased significantly (163%) in control samples and not in treated samples. Tumor necrosis factor alpha was detectable only in control samples at closure. During surgery, tPA levels showed a marked decrease in control samples vs. a small increase in treated samples. Levels of uPA increased significantly only in the control samples. In control samples, tPA/PAI-1 ratio was two thirds of treated sample ratio. Conclusion(s): Heating of the peritoneum with the PROACT™ System modulates the biologic tissue response to induce effects that would be consistent with inhibition of postoperative adhesion development.

KW - Adhesions

KW - Incision line

KW - Plasminogen activator

KW - Plasminogen activator inhibitor-1

KW - Postoperative adhesions

KW - PROACT™ System

KW - Transforming growth factor-beta

UR - http://www.scopus.com/inward/record.url?scp=0344211524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344211524&partnerID=8YFLogxK

U2 - 10.1016/S0015-0282(02)04851-3

DO - 10.1016/S0015-0282(02)04851-3

M3 - Article

VL - 79

SP - 987

EP - 992

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 4

ER -